文献速递骨肌胸部技术与安全CT

100-kVp LDCT L1衰减值预测绝经后女性10年脆性骨折风险

Opportunistic L1 Attenuation on 100-kVp LDCT Predicts Ten-Year Fragility Fracture Risk in Postmenopausal Women in a Self-Paid Health Check-up Cohort.
PubMed 文献 · Acad Radiol · 2026-08-05

回顾性队列纳入1464例≥50岁女性,中位随访10.1年,以100-kVp LDCT测量L1 HU,并由246例配对DXA校准队列确定阈值。L1 HU≤160提示低骨密度,10年椎体骨折累计发生率为38.2%对2.8%,复合脆性骨折为48.1%对6.3%。低骨密度是椎体骨折的独立预测因素(校正HR 2.54,95% CI 1.33-4.85,p=0.005)。

要点

  • L1 HU≤160在100-kVp LDCT上提示低骨密度,相关10年骨折风险约高3倍
  • 常规肺癌筛查LDCT即可免费获得骨健康信息,无需额外扫描
  • 椎体HU测量可作为FRAX未含BMD时相当的骨折风险分层工具

核心结论

  • 100-kVp LDCT上L1衰减值≤160 HU识别绝经后女性脆性骨折风险升高约三倍,性能与不含BMD的FRAX工具相当

研究设计与样本

  • 回顾性队列研究,纳入1464例≥50岁女性,中位随访10.1年
  • 由两名独立阅片者在100-kVp LDCT上测量L1 HU
  • 正常与低骨密度参考值来自独立校准队列(n=246),含配对LDCT-DXA数据,AUC 0.841
  • 研究终点为椎体骨折事件及复合主要脆性骨折事件

关键影像表现/征象

  • HU=160作为分层阈值,>160 HU为正常骨密度组(n=952),≤160 HU为低骨密度组(n=512)
  • 低骨密度组10年椎体骨折累计发生率为38.2%,正常组为2.8%
  • 低骨密度组复合脆性骨折累计发生率为48.1%,正常组为6.3%

诊断标准与关键数值

  • L1 HU≤160在100-kVp LDCT上提示低骨密度,AUC 0.841
  • 椎体骨折发生率比为3.46(95% CI 2.62-4.57)
  • 全部脆性骨折发生率比为2.72(95% CI 2.14-3.46)
  • 多变量Cox回归校正年龄、体重指数及合并症后,低骨密度(≤160 HU)仍为椎体骨折独立预测因素(校正HR 2.54,95% CI 1.33-4.85,p=0.005)

临床应用与阅片要点

  • 在100-kVp LDCT肺癌筛查或健康体检中常规测量L1椎体HU,≤160 HU时在报告中提示骨密度减低及骨折风险升高
  • 该测量不增加额外扫描或辐射剂量,可作为机会性骨质疏松筛查融入现有LDCT工作流程
  • 对L1 HU处于低值者建议进一步行DXA确认或启动骨健康管理

局限性

  • 研究为回顾性队列设计,可能存在选择偏倚
  • 研究对象来自自费健康体检人群,结果外推至其他人群需谨慎

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Low-dose computed tomography (LDCT) is standard for lung cancer screening, yet validated fracture risk thresholds for 100-kVp protocols have not been established in health check-up cohorts. We evaluated whether L1 vertebral attenuation on 100-kVp LDCT predicts 10-year fragility fracture incidence.

MATERIALS AND METHODS: This retrospective cohort study included 1464 women age ≥50 years (median follow-up: 10.1 years). L1 Hounsfield Units (HU) were measured on 100-kVp LDCT by two independent readers. References value for normal and low bone mineral density (BMD) was derived from a separate calibration cohort (n = 246) with paired LDCT-Dual-energy X-ray absorptiometry (DXA) data (AUC 0.841). Endpoints included incident vertebral fractures and composite major fragility fractures.

RESULTS: HU = 160 (AUC = 0.841) stratified the whole group into normal BMD (>160 HU; n = 952) and low BMD (≤160 HU; n = 512). At 10 years, cumulative vertebral fracture incidence was 38.2 vs. 2.8% in low vs. normal BMD groups; composite fractures reached 48.1% vs. 6.3%. The incidence rate ratio was 3.46 (95% CI: 2.62-4.57) for vertebral fractures and 2.72 (95% CI: 2.14-3.46) for all fragility fractures. On multivariable Cox regression adjusting for age, body mass index, and comorbidities, low BMD (≤160 HU) remained an independent predictor of vertebral fracture (adjusted HR: 2.54; 95% CI: 1.33-4.85; p = 0.005).

CONCLUSION: L1 attenuation ≤160 HU on 100-kVp LDCT identified postmenopausal women at three-fold higher fragility fracture risk, with performance comparable to Fracture Risk Assessment Tool without BMD. In this healthy screenee cohort, L1 HU serves as the primary bone health signal, enabling early identification of at-risk individuals within existing LDCT workflows at no additional cost.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Lin, Lee, Wu, et al. Opportunistic L1 Attenuation on 100-kVp LDCT Predicts Ten-Year Fragility Fracture Risk in Postmenopausal Women in a Self-Paid Health Check-up Cohort. Acad Radiol. 2026. PMID: 42557202. doi:10.1016/j.acra.2026.07.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。